+351 211 369 829 
Ophiomics- Precision Medicine
Ophiomics is a clinical-stage, ISO 13485 and ISO 9001 certified medtech company dedicated to precision liver medicine. We develop cutting-edge diagnostic products that integrate artificial intelligence and genomics-supporting diagnosis, prognosis, treatment selection, and clinical follow-up for liver disease.
Vision & Mission
Our vision: Empowering a new era in hepatology-where responsible AI-driven precision medicine conquers liver disease, saves lives, and unlocks longer, healthier futures.
Our Mission: Our mission is to develop and deliver clinically validated, responsible AI-powered algorithms, omics-based diagnostics, and intelligent platforms that empower healthcare professionals to detect and manage liver disease with unprecedented precision, transparency, and trust.
Our Values
At Ophiomics, our work is guided by a commitment to ethical innovation, scientific integrity, and a patient-centered approach to healthcare.
Responsible AI
We design and deploy artificial intelligence that is transparent, fair, explainable, and accountable-ensuring trust and safety for clinicians and patients.
Ethical Integrity
We adhere to the highest standards of scientific and clinical ethics in all our research, partnerships, and products.
Patient-Centricity
Every decision we make is focused on improving outcomes and experiences for patients with liver disease.
Equity & Inclusion
We strive to make our innovations accessible and beneficial to all, regardless of geography or background.
Sustainability
We are committed to sustainable practices in our research, operations, and product development.
Values in action
Our commitment to better liver health is built on these core principles, shaping everything we do-from research to real-world impact
Actionable
We create practical tools to empower clinicians’ decisions at crucial stages in the liver disease patient journey, where preventative or curative interventions are possible.
Novel
We leverage the power of genomics and Machine Learning to discover novel biomarkers that address unmet clinical needs.
Integrative
We integrate biomarkers and clinical variables through cutting-edge machine-learning algorithms, creating solutions to support clinicians’ decisions.
Accessible
Our end-products - Software and IVD medical devices – are designed to seamlessly integrate into routine clinical practice, ensuring accessibility and ease of adoption
Collaborative
We value partnerships with clinicians, academia, patients, and companies, to build upon and advance our approaches, seeking improved outcomes for all.
